A photo of Christopher Siracusa.

Associate Director, Cystic Fibrosis Center

Assistant Professor, UC Department of Pediatrics


Board Certified

About Me

Academic Affiliation

Assistant Professor, UC Department of Pediatrics


Pulmonary Medicine, Cystic Fibrosis

My Locations

My Education

MD: American University of the Caribbean, Netherlands, Antilles, 2009.

Residency: Akron Children’s Hospital/NEOUCOM, Akron, OH, 2012.

My Publications

Acute Respiratory Distress Syndrome immediately following the removal of an aspirated foreign body. Simpson, R; Myer IV, C; Siracusa, C. Respiratory Medicine Case Reports. 2020; 29:100978-100978.

Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis with Ivacaftor: Case Series. Carrion, A; Borowitz, DS; Freedman, SD; Siracusa, CM; Goralski, JL; Hadjiliadis, D; Srinivasan, S; Stokes, DC. Journal of Pediatric Gastroenterology and Nutrition. 2018; 66:451-454.

CFTR Modulator Therapies in Cystic Fibrosis. Spielberg, DR; Clancy, JP; Siracusa, C. TREATMENT OF CYSTIC FIBROSIS AND OTHER RARE LUNG DISEASES. : Springer Basel; Springer Basel; 2017.

Non-typeable Haemophilus influenzae purulent pericarditis in a child with cystic fibrosis. Downes, KJ; Abulebda, K; Siracusa, C; Moore, R; Staat, MA; Poynter, SE. Pediatrics International. 2016; 58:607-609.

Update in Pediatric Lung Disease 2014. Siracusa, CM; Brewington, JJ; Brockbank, JC; Guilbert, TW. American Journal of Respiratory and Critical Care Medicine. 2015; 192:918-923.

Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor. Siracusa, CM; Ryan, J; Burns, L; Wang, Y; Zhang, N; Clancy, JP; Drotar, D. Journal of Cystic Fibrosis. 2015; 14:621-626.

Adherence Determinants in Cystic Fibrosis: Cluster Analysis o f Parental Psychosocial, Religious, and/or Spiritual Factors. Grossoehme, DH; Szczesniak, RD; Britton, LL; Siracusa, CM; Quittner, AL; Chini, BA; Dimitriou, SM; Seid, M. Annals of the American Thoracic Society. 2015; 12:838-846.